AAAAAA

   
Results: 1-15 |
Results: 15
THE IMMUNE-RESPONSE TO BREAST-CANCER
Authors: SCHOLL SM BARON C SALAMARO J BEUZEBOC P DENEUX L BEUVON F POUILLART P
Citation: Sm. Scholl et al., THE IMMUNE-RESPONSE TO BREAST-CANCER, European journal of cancer, 34, 1998, pp. 149-149
CONTROL AND MANIPULATION OF MALIGNANT-TUMOR SPREAD - 2ND INSTITUT-CURIE-ONCOLOGY-CONFERENCE 5-8 JUNE, 1996
Authors: SCHOLL SM
Citation: Sm. Scholl, CONTROL AND MANIPULATION OF MALIGNANT-TUMOR SPREAD - 2ND INSTITUT-CURIE-ONCOLOGY-CONFERENCE 5-8 JUNE, 1996, Breast, 6(3), 1997, pp. 164-166
PHASE-II TRIAL OF DOXORUBICIN, 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA
Authors: PIERGA JY DIERAS V BEUZEBOC P DORVAL T PALANGIE T JOUVE M SCHOLL SM GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., PHASE-II TRIAL OF DOXORUBICIN, 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA, Gynecologic oncology, 66(2), 1997, pp. 246-249
VACCINATION AGAINST THE POLYMORPHIC EPITH ELIAL MUCINE MUC1 COMMONLY OVEREXPRESSED IN BREAST-CANCER
Authors: SCHOLL SM POUILLART P
Citation: Sm. Scholl et P. Pouillart, VACCINATION AGAINST THE POLYMORPHIC EPITH ELIAL MUCINE MUC1 COMMONLY OVEREXPRESSED IN BREAST-CANCER, Bulletin du cancer, 84(1), 1997, pp. 61-64
METACHRONOUS CONTRALATERAL BREAST-CANCER AS FIRST EVENT OF RELAPSE
Authors: DELAROCHEFORDIERE A MOURETFOURME E ASSELAIN B SCHOLL SM CAMPANA F BROET P FOURQUET A
Citation: A. Delarochefordiere et al., METACHRONOUS CONTRALATERAL BREAST-CANCER AS FIRST EVENT OF RELAPSE, International journal of radiation oncology, biology, physics, 36(3), 1996, pp. 615-621
CIRCULATING LEVELS OF THE MACROPHAGE-COLONY-STIMULATING FACTOR CSF-1 IN PRIMARY AND METASTATIC BREAST-CANCER PATIENTS - A PILOT-STUDY
Authors: SCHOLL SM LIDEREAU R DELAROCHEFORDIERE A LENIR CCS MOSSERI V NOGUES C POUILLART P STANLEY ER
Citation: Sm. Scholl et al., CIRCULATING LEVELS OF THE MACROPHAGE-COLONY-STIMULATING FACTOR CSF-1 IN PRIMARY AND METASTATIC BREAST-CANCER PATIENTS - A PILOT-STUDY, Breast cancer research and treatment, 39(3), 1996, pp. 275-283
TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH COMBINATION OF ETOPOSIDE, CISPLATIN, AND 5-FLUOROURACIL - A PHASE-II STUDY
Authors: PIERGA JY DIERAS V PARAISO D DORVAL T PALANGIE T BEUZEBOC P JOUVE M SCHOLL SM GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH COMBINATION OF ETOPOSIDE, CISPLATIN, AND 5-FLUOROURACIL - A PHASE-II STUDY, Gynecologic oncology, 60(1), 1996, pp. 59-63
CONTRALATERAL BREAST-CANCER - METASTASIS OR 2ND PRIMARY-CANCER
Authors: BROET P DELAROCHEFORDIERE A SCHOLL SM FOURQUET A MOSSERI V DURAND JC POUILLART P ASSELAIN B
Citation: P. Broet et al., CONTRALATERAL BREAST-CANCER - METASTASIS OR 2ND PRIMARY-CANCER, Bulletin du cancer, 83(10), 1996, pp. 870-876
BREAST-TUMOR RESPONSE TO PRIMARY CHEMOTHERAPY PREDICTS LOCAL AND DISTANT CONTROL AS WELL AS SURVIVAL
Authors: SCHOLL SM PIERGA JY ASSELAIN B BEUZEBOC P DORVAL T GARCIAGIRALT E JOUVE M PALANGIE T REMVIKOS Y DURAND JC FOURQUET A POUILLART P
Citation: Sm. Scholl et al., BREAST-TUMOR RESPONSE TO PRIMARY CHEMOTHERAPY PREDICTS LOCAL AND DISTANT CONTROL AS WELL AS SURVIVAL, European journal of cancer, 31A(12), 1995, pp. 1969-1975
CONTRALATERAL BREAST-CANCER - ANNUAL INCIDENCE AND RISK PARAMETERS
Authors: BROET P DELAROCHEFORDIERE A SCHOLL SM FOURQUET A MOSSERI V DURAND JC POUILLART P ASSELAIN B
Citation: P. Broet et al., CONTRALATERAL BREAST-CANCER - ANNUAL INCIDENCE AND RISK PARAMETERS, Journal of clinical oncology, 13(7), 1995, pp. 1578-1583
ANTI-COLONY-STIMULATING FACTOR-I ANTIBODY STAINING IN PRIMARY BREAST ADENOCARCINOMAS CORRELATES WITH MARKED INFLAMMATORY CELL INFILTRATES AND PROGNOSIS
Authors: SCHOLL SM PALLUD C BEUVON F HACENE K STANLEY ER ROHRSCHNEIDER L TANG R POUILLART P LIDEREAU R
Citation: Sm. Scholl et al., ANTI-COLONY-STIMULATING FACTOR-I ANTIBODY STAINING IN PRIMARY BREAST ADENOCARCINOMAS CORRELATES WITH MARKED INFLAMMATORY CELL INFILTRATES AND PROGNOSIS, Journal of the National Cancer Institute, 86(2), 1994, pp. 120-126
NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL PATIENTS WITH TUMORS CONSIDERED TOO LARGE FOR BREAST-CONSERVING SURGERY - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL - S6
Authors: SCHOLL SM FOURQUET A ASSELAIN B PIERGA JY VILCOQ JR DURAND JC DORVAL T PALANGIE T JOUVE M BEUZEBOC P GARCIOGIRALT E SALMON RJ DELAROCHEFORDIERE A CAMPANA F POUILLART P
Citation: Sm. Scholl et al., NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL PATIENTS WITH TUMORS CONSIDERED TOO LARGE FOR BREAST-CONSERVING SURGERY - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL - S6, European journal of cancer, 30A(5), 1994, pp. 645-652
CIRCULATING LEVELS OF COLONY-STIMULATING FACTOR-1 AS A PROGNOSTIC INDICATOR IN 82 PATIENTS WITH EPITHELIAL OVARIAN-CANCER
Authors: SCHOLL SM BASCOU CH MOSSERI V OLIVARES R MAGDELENAT H DORVAL T PALANGIE T VALIDIRE P POUILLART P STANLEY ER
Citation: Sm. Scholl et al., CIRCULATING LEVELS OF COLONY-STIMULATING FACTOR-1 AS A PROGNOSTIC INDICATOR IN 82 PATIENTS WITH EPITHELIAL OVARIAN-CANCER, British Journal of Cancer, 69(2), 1994, pp. 342-346
IS COLONY-STIMULATING FACTOR-I A KEY MEDIATOR OF BREAST-CANCER INVASION AND METASTASIS
Authors: SCHOLL SM CROCKER P TANG RP POUILLART P POLLARD JW
Citation: Sm. Scholl et al., IS COLONY-STIMULATING FACTOR-I A KEY MEDIATOR OF BREAST-CANCER INVASION AND METASTASIS, Molecular carcinogenesis, 7(4), 1993, pp. 207-211
AGE AS PROGNOSTIC FACTOR IN PREMENOPAUSAL BREAST-CARCINOMA
Authors: DELAROCHEFORDIERE A ASSELAIN B CAMPANA F SCHOLL SM FENTON J VILCOQ JR DURAND JC POUILLART P MAGDELENAT H FOURQUET A
Citation: A. Delarochefordiere et al., AGE AS PROGNOSTIC FACTOR IN PREMENOPAUSAL BREAST-CARCINOMA, Lancet, 341(8852), 1993, pp. 1039-1043
Risultati: 1-15 |